TABLE 3.
Gender | Model | Genotype | PR2 | 95% CI |
P | |
Male | Additive | CT vs. CC | 1.06 | 0.93 | 1.21 | 0.68 |
TT vs. CC | 1.12 | 0.86 | 1.46 | |||
Female | Additive | CT vs. CC | 1.25 | 1.09 | 1.43 | <0.01 |
TT vs. CC | 1.56 | 1.19 | 2.04 | |||
Male | Co-dominant | CT vs. CC | 1.17 | 0.94 | 1.46 | 0.15 |
TT vs. CC | 1.10 | 0.83 | 1.46 | 0.52 | ||
Female | Co-dominant | CT vs. CC | 1.34 | 1.05 | 1.71 | 0.02 |
TT vs. CC | 1.56 | 1.18 | 2.06 | <0.01 |
Likelihood ratio test value for the multiplicative interaction between sex and rs1502593 = 0.068. MetS, metabolic syndrome.
PR, prevalence ratio; adjusted for individual admixture proportion and age.